June 1, 2020 / 12:32 PM / a month ago

BRIEF-Aimmune Therapeutics Says New Palforzia Data On Long-Term Safety, Efficacy And Immunomodulation To Be Presented At EAACI

June 1 (Reuters) - Aimmune Therapeutics Inc:

* AIMMUNE THERAPEUTICS INC - NEW PALFORZIA DATA ON LONG-TERM SAFETY, EFFICACY AND IMMUNOMODULATION TO BE PRESENTED AT EAACI 2020 CONGRESS

* AIMMUNE THERAPEUTICS INC - NEW DATA ON PATIENT SATISFACTION WITH PALFORZIA TREATMENT TO BE PRESENTED AT EAACI 2020 CONGRESS

* AIMMUNE THERAPEUTICS INC - IMPORTANT DATA ON PSYCHOSOCIAL BURDEN OF PEANUT ALLERGY ON CHILDREN AND CAREGIVERS ALSO TO BE PRESENTED Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below